Meseguer Ripolles, J, Wang, Y, Sorteberg, A, Sharma, A, Ding, N-L, Lucendo Villarin, B, Krämer, P, Segeritz, C-P & Hay, D 2020, ' Hepatic Progenitor Specification from Pluripotent Stem Cells Using a Defined Differentiation System ', Journal of Visualized Experiments (JoVE), no. 159, e61256 . https://doi.org/10.3791/6125
Liver disease is an escalating global health issue. While liver transplantation is an effective mode of therapy, patient mortality has increased due to shortages in donor organ availability. Organ scarcity also affects the routine supply of human hepatocytes for basic research and the clinic. Therefore, the development of renewable sources of human liver progenitor cells is desirable and is the goal of this study. To be able to effectively generate and deploy human liver progenitors on a large scale, a reproducible hepatic progenitor differentiation system was developed. This protocol aids experimental reproducibility between users in a range of cell cultureware formats and permits differentiations using both, human embryonic and induced pluripotent stem cell lines. These are important advantages over current differentiation systems that will enhance the basic research and may pave the way towards clinical product development.
